相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nanoparticle-induced ferroptosis: detection methods, mechanisms and applications
Huizhen Zheng et al.
NANOSCALE (2021)
Radiation-Induced Lipid Peroxidation Triggers Ferroptosis and Synergizes with Ferroptosis Inducers
Ling F. Ye et al.
ACS CHEMICAL BIOLOGY (2020)
Two-Dimensional Tin Selenide (SnSe) Nanosheets Capable of Mimicking Key Dehydrogenases in Cellular Metabolism
Meng Gao et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Engineering the Protein Corona Structure on Gold Nanoclusters Enables Red-Shifted Emissions in the Second Near-infrared Window for Gastrointestinal Imaging
Weili Wang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers
Mariluz Soula et al.
NATURE CHEMICAL BIOLOGY (2020)
Vacancies on 2D transition metal dichalcogenides elicit ferroptotic cell death
Shujuan Xu et al.
NATURE COMMUNICATIONS (2020)
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Iuliia Efimova et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Rui-Xue Huang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Porous platinum nanoparticles as a high-Z and oxygen generating nanozyme for enhanced radiotherapy in vivo
Yan Li et al.
BIOMATERIALS (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Engineered Graphene Oxide Nanocomposite Capable of Preventing the Evolution of Antimicrobial Resistance
Huizhen Zhen et al.
ACS NANO (2019)
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing et al.
MOLECULAR CANCER (2019)
Exploring the interactions between engineered nanomaterials and immune cells at 3D nano-bio interfaces to discover potent nano-adjuvants
Ronglin Ma et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
FSP1 is a glutathione-independent ferroptosis suppressor
Sebastian Doll et al.
NATURE (2019)
Characterization of hypoxia-associated molecular features to aid hypoxia-targeted therapy
Youqiong Ye et al.
NATURE METABOLISM (2019)
Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles
Zaigang Zhou et al.
THERANOSTICS (2018)
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
Mal Irvine et al.
ONCOGENESIS (2018)
Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
Christian U. Blank et al.
NATURE MEDICINE (2018)
Multi-hierarchical profiling the structure-activity relationships of engineered nanomaterials at nano-bio interfaces
Xiaoming Cai et al.
NATURE COMMUNICATIONS (2018)
Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition
Matthew J. Hangauer et al.
NATURE (2017)
miR-25/93 mediates hypoxia-induced immunosuppression by repressing cGAS
Min-Zu Wu et al.
NATURE CELL BIOLOGY (2017)
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
Guangbao Yang et al.
NATURE COMMUNICATIONS (2017)
Confining Excitation Energy in Er3+-Sensitized Upconversion Nanocrystals through Tm3+-Mediated Transient Energy Trapping
Qiushui Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
TaOx decorated perfluorocarbon nanodroplets as oxygen reservoirs to overcome tumor hypoxia and enhance cancer radiotherapy
Guosheng Song et al.
BIOMATERIALS (2017)
Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials
Georgina V. Long et al.
LANCET ONCOLOGY (2016)
Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells
G. Pathria et al.
CELL DEATH & DISEASE (2016)
12/15-lipoxygenase-mediated enzymatic lipid oxidation regulates DC maturation and function
Tobias Rothe et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Immunological mechanisms of the antitumor effects of supplemental oxygenation
Stephen M. Hatfield et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
Holly E. Barker et al.
NATURE REVIEWS CANCER (2015)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
James Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma
Georgina V. Long et al.
NATURE COMMUNICATIONS (2014)
Rare-earth-doped biological composites as in vivo shortwave infrared reporters
D. J. Naczynski et al.
NATURE COMMUNICATIONS (2013)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma
Alexander M. Menzies et al.
CLINICAL CANCER RESEARCH (2012)
DNA repair dysregulation from cancer driver to therapeutic target
Nicola J. Curtin
NATURE REVIEWS CANCER (2012)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
Gideon Bollag et al.
NATURE (2010)
Quantitative assays for esterified oxylipins generated by immune cells
Alwena H. Morgan et al.
NATURE PROTOCOLS (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease
Salvador Mena et al.
CLINICAL CANCER RESEARCH (2007)
Mechanisms of disease - Melanoma
Arlo J. Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Death receptors and melanoma resistance to apoptosis
VN Ivanov et al.
ONCOGENE (2003)
Catalytic reaction mechanism of lipoxygenase. A density functional theory study
T Borowski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2003)
分享论文
